Xenon Pharmaceuticals Inc.
Records under this name other than the patents Xenon Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 22 patents it holds.
Back to Xenon Pharmaceuticals Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,450,358 | Enantiomers of Spiro-Oxindole Compounds and Their Uses as Therapeutic Agents Formerly held In force · High confidence | In force | High confidence | |
| US 9,504,671 | Pharmaceutical Compositions of Spiro-Oxindole Compound for Topical Administration and Their Use as Therapeutic Agents Formerly held In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 8,445,696 | Synthetic Methods for Spiro-Oxindole Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 9,487,535 | Asymmetric Syntheses for Spiro-Oxindole Compounds Useful as Therapeutic Agents Formerly held In force · High confidence | In force | High confidence | |
| US 9,682,033 | Methods of Treating Postherpetic Neuralgia with a Topical Formulation of a Spiro-Oxindole Compound Formerly held In force · High confidence | In force | High confidence | |
| US 10,787,446 | Therapeutic Compounds and Methods of Use Thereof Held by another company In force · Medium confidence | In force | Medium confidence | |
| US 10,100,060 | Asymmetric Synthesis of Funapide Formerly held In force · High confidence | In force | High confidence | |
| US 10,118,932 | Solid State Forms of Spiro-Oxindole Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 10,005,724 | Therapeutic Compounds and Methods of Use Thereof Lapsed on the fee record Ended Jun 26, 2026 · High confidence | Lapsed on the fee record | Ended Jun 26, 2026 | High confidence |
| US 8,106,087 | Spiro-oxindole compounds and their uses as therapeutic agents Term ended Ended no later than Apr 11, 2026 · USPTO record | Term ended | Ended no later than Apr 11, 2026 | USPTO record |